• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Clopidogrel Teva
    / Teva


    Active Ingredient
    Clopidogrel (as bisulfate) 75 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 75 mg (Blister)

    partial basket chart 89487 3941

    Tablets

    30 X 75 mg (Bottle)

    partial basket chart 80638 3961

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    For the prevention of atherothrombotic events as follows: Recent myocardial infarction (MI), recent stroke or established peripheral arterial disease. Patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. For patients with a history of recent MI, recent stroke, or established peripheral arterial disease, clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not), and other vascular death.For patients with acute coronary syndrome Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave MI) or ST segment elevation acute MI in combination with acetylsalicylic acid (ASA) in medicdbally treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or CABG, clopidogrel has been shown to decrease the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia.


    Contra-Indications

    Hypersensitivity to the active substance or to any of the excipients of the product. Severe liver impairment. Active pathological bleeding such as peptic ulcer or intracranial hemorrhage. Lactation.


    Special Precautions

    Please contact manufacturer/distributing company for full details.


    Side Effects

    Please contact manufacturer/distributing company for full details.


    Drug interactions

    Please contact manufacturer/distributing company for full details.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE